feed,title,long_url,short_url
InsiderMonkey,Boston Omaha Corporation (BOC): A Bull Case Theory,https://insidermonkey.com/blog/--1537189,
InsiderMonkey,Nebius Group N.V. (NBIS): A Bull Case Theory,https://insidermonkey.com/blog/--1537199,
InsiderMonkey,"NVR, Inc. (NVR): A Bull Case Theory",https://insidermonkey.com/blog/--1537202,
InsiderMonkey,"Merck & Co., Inc. (MRK): A Bull Case Theory",https://insidermonkey.com/blog/--1537206,
InsiderMonkey,"Cisco Systems, Inc. (CSCO): A Bull Case Theory",https://insidermonkey.com/blog/--1537210,
InsiderMonkey,"NIKE, Inc. (NKE): A Bull Case Theory",https://insidermonkey.com/blog/--1537212,
InsiderMonkey,"Medpace Holdings, Inc. (MEDP): A Bull Case Theory",https://insidermonkey.com/blog/--1537249,
InsiderMonkey,"Omega Healthcare Investors, Inc. (OHI): A Bull Case Theory",https://insidermonkey.com/blog/--1537251,
InsiderMonkey,"Match Group, Inc. (MTCH): A Bull Case Theory",https://insidermonkey.com/blog/--1537256,
InsiderMonkey,"Jasper Therapeutics, Inc. (JSPR): Analysts See 914% Upside Potential",https://insidermonkey.com/blog/--1534682,
InsiderMonkey,"Larimar Therapeutics, Inc.’s (LRMR): Analysts See 957% Upside Potential",https://insidermonkey.com/blog/--1534676,
InsiderMonkey,"Capricor Therapeutics, Inc.’s (CAPR): Analysts See 489% Upside Potential",https://insidermonkey.com/blog/--1534660,
InsiderMonkey,"Perspective Therapeutics, Inc. (CATX): Analysts See 460% Upside Potential",https://insidermonkey.com/blog/--1534653,
InsiderMonkey,"aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential",https://insidermonkey.com/blog/--1534641,
InsiderMonkey,AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential,https://insidermonkey.com/blog/--1534629,
InsiderMonkey,"Lexicon Pharmaceuticals, Inc. (LXRX): Analysts See 285% Upside Potential",https://insidermonkey.com/blog/--1534611,
InsiderMonkey,Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential,https://insidermonkey.com/blog/--1534618,
InsiderMonkey,"Could Altimmune, Inc. (ALT): Analysts See 288% Upside Potential",https://insidermonkey.com/blog/--1534604,
InsiderMonkey,"Aquestive Therapeutics, Inc. (AQST): Analysts See 245% Upside Potential",https://insidermonkey.com/blog/--1534531,
InsiderMonkey,Savara Inc. (SVRA): Analysts See 212% Upside Potential,https://insidermonkey.com/blog/--1534516,
